The Programme

An educational programme with extensive opportunities for audience participation, sharing and learning through experiences and asking questions to peers and experts.

The Masterclass will start at 12:00 on Friday 18th October and finish at 15:45 on Saturday 19th October. There will be a dinner for all attendees on Friday 18th October.

The detailed programme can be found here: Pituitary Masterclass

The programme will cover the following areas:

• Opening Lecture: Neurosurgery

Plenary Sessions:

• Acromegaly
• PTCOE (Pituitary Tumours Centre of Excellence)
• Cushing’s Disease
• Novel Treatments in pituitary disease
• Special clinical issues in pituitary disease

Meet the Expert Sessions:

• Management of pituitary adenomas
• Outcomes in pituitary adenomas
• Patient session: Acromegaly FAQs

Breakout sessions:

• Aggressive pituitary tumours
• Diabetes insipidus
• Pituitary imaging

Disclosures

SCIENTIFIC COMMITTEE

• Prof Andrea Giustina has the following relevant financial information to disclose: Grants/Consultancy (Abiogen, Astellas, Ipsen, Novartis, Pfizer)
• Prof Felipe Casanueva has the following relevant financial information to disclose: Grants/Consultancy (Ipsen)
• Prof Philippe Chanson has the following relevant financial information to disclose: Grants (Ipsen, Novartis, Novo-Nordisk, Pfizer, Tiburio)
• Prof Maria Fleseriu has the following relevant financial information to disclose: Grants/Consultancy (Chiasma, Ionis, Ipsen, Millendo, Novartis, Novo-Nordisk, Pfizer, Strongbridge)
• Prof Stephan Petersenn has the following relevant financial information to disclose: Grants/Consultancy (Ipsen, Novartis, Pfizer)

FACULTY

• Prof Pietro Mortini does not have any relevant financial relationship to disclose
• Prof Anton Luger has the following relevant financial information to disclose: Grants/Consultancy (Ipsen, Novo-Nordisk, Novartis, Pfizer, Sandoz)
• Prof Marco Losa does not have any relevant financial relationship to disclose
• Prof Stefano Frara has the following relevant financial information to disclose: Grants/Consultancy (Ipsen)
• Prof Nienke Biermasz does not have any relevant financial relationship to disclose
• Dr Francesco Tecilazich does not have any relevant financial relationship to disclose
• Dr Anna Formenti has the following relevant financial information to disclose: Grants/Consultancy (Abiogen, Sandoz)
• Prof Luca Persani has the following relevant financial information to disclose: Grants/Consultancy (Merck-Serono, Sandoz)
• Prof Monika Marazuela does not have any relevant financial relationship to disclose
• Prof Martin Reincke does not have any relevant financial relationship to disclose
• Prof Ezio Ghigo does not have any relevant financial relationship to disclose
• Prof AnaMaria Colao has the following relevant financial information to disclose: Grants/Consultancy (Ipsen, Novartis, Pfizer)
• Prof Thierry Brue has the following relevant financial information to disclose: Grants/Consultancy (Ipsen, Novartis, Pfizer)
• Prof Laura DeMarinis does not have any relevant financial relationship to disclose
• Dr Eugene Resmini does not have any relevant financial relationship to disclose
• Prof Prof Niki Karavitaki has the following relevant financial information to disclose: Grants/Consultancy (Novartis, Pfizer)
• Prof Paolo Loli does not have any relevant financial relationship to disclose
• Dr Raphael Souillard-Scemama does not have any relevant financial relationship to disclose

PLANNING COMMITTEE

• Iain Murdoch of COR2ED has the following relevant financial information to disclose: Shareholder (AstraZeneca)

This programme is supported by an Independent Educational Grant from Ipsen

PITUITARY CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Ipsen.